Dishman Pharmaceuticals and Chemicals Ltd.
Dishman Pharmaceuticals & Chemicals Ltd. (Dishman) is a public company that is engaged in manufacturing and commercialization of bulk drugs, intermediates, quaternary compounds (quats), and specialty chemicals globally. It principally produces intermediates, fine chemicals, and products for the pharmaceutical, cosmetic and related industries. In addition, the company also offers vitamin d3, specialty chemicals, and cholesterol and cholesterol derivatives; and intermediates and active pharmaceutical ingredients for various applications, including antiseptic formulations, gastroenteric formulations, cosmeceutical preparations, and cardiovascular and antipsychotic formulations, and also manufactures hospital disinfectants. Further, the company provides various outsourcing services, including contract research and contract manufacturing. Dishman has its presence in Europe, China and India. The company is headquartered at Ahmedabad in Gujarat, India.The company reported revenues of (Rupee) INR 10,671.18 million during the fiscal year ended March 2009, an increase of 25.43% over 2008. The operating profit of the company was INR 1,574.56 million during the fiscal year 2009, an increase of 28.17% over 2008. The net profit of the company was INR 1,467.41 million during the fiscal year 2009, an increase of 20.76% over 2008.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

